Cancer Immunotherapy Conference is dedicated to development related to the stem cells and cancer immunotherapy and cover topics such as:
- Reprogramming Tumor-Immune Crosstalk to Overcome Breast Cancer Relapse
- Using Stem Cell-like T Cells in the Adoptive Immunotherapy of Cancer
- EGFRvIII and Cancer Stem Cells: Why a Rarely Expressed Tumor Antigen Is a Good Cancer Vaccine Target
- Programming Stem Cells and T Cells for Adoptive T Cell Immunotherapy
- Biology and Immune Targeting of Cancer Stem Cells
- SSX2 - A Vaccine Target Antigen Expressed by Prostate Cancer Cells with Stem-cell Like Properties
- Cancer Testes Antigens as Targets for Tumor Relapse in Solid and Hematological Cancers
- The Translational Biology of Cancer Stem Cells
- Autologous Cancer Stem Cells in Immunotherapy
- Targeting of Cancer Stem Cells Through Antibody Therapy
Who should Attend
Leading scientists and C-Level executives.
